Advair combines two medications: an inhaled corticosteroid (fluticasone) that reduces airway inflammation and a long-acting bronchodilator (salmeterol) that keeps airways open. Most short-term side effects like headache and throat irritation are well known, but people using Advair for months or years face a different set of concerns. The corticosteroid component drives most of the long-term risks, and those risks generally increase with higher doses and longer use.
Oral Thrush and Voice Changes
The most common local side effect of long-term Advair use is oral thrush, a yeast infection caused by Candida that develops in the mouth and throat. Every dose of Advair deposits some corticosteroid on the soft tissues of your mouth and pharynx, and over time this suppresses local immune defenses enough for yeast to overgrow. You may notice white patches on your tongue, inner cheeks, or the roof of your mouth, sometimes with soreness or a cottony feeling.
Hoarseness and voice changes (dysphonia) are also common with extended use. The corticosteroid can irritate the vocal cords, making your voice raspy or weak. Both problems are manageable: rinsing your mouth with water and spitting it out after every dose significantly reduces the risk. The FDA labeling for Advair specifically recommends this step. If thrush does develop, it’s typically treated with an antifungal while you continue using Advair, though occasionally treatment needs to be paused.
Pneumonia Risk, Especially in COPD
Pneumonia is the most serious infection risk tied to long-term Advair use, and COPD patients face a notably higher risk than people with asthma. In two 12-month clinical trials involving over 1,500 COPD patients, 7% of those using Advair developed pneumonia compared with 3% of those using the bronchodilator component alone. A larger three-year study of more than 6,100 COPD patients found pneumonia rates of 16% with Advair versus 9% with placebo.
The inhaled corticosteroid suppresses immune activity in the airways, which is exactly how it controls inflammation, but it also makes the lungs slightly less equipped to fight off bacteria. This tradeoff is why doctors weigh pneumonia risk carefully when prescribing Advair for COPD at higher doses or for extended periods. If you develop a new cough with fever, increased mucus production, or worsening breathlessness while on Advair, those symptoms warrant prompt evaluation.
Effects on Bone Density
Because oral corticosteroids are well known to thin bones, many long-term Advair users worry about osteoporosis. The evidence here is more reassuring than you might expect. A study of 658 COPD patients who received annual bone density scans found that three years of inhaled fluticasone at double the standard COPD dose did not reduce bone mineral density compared with patients who received no inhaled corticosteroid. Changes in bone density were small and similar in both groups, and fracture rates were not significantly different.
That said, osteoporosis was already very common in this population before anyone started treatment: 18% of men and 30% of women had osteoporosis at baseline. Inhaled corticosteroids deliver far lower systemic doses than oral steroids, which explains why the bone impact is minimal. Still, if you’re already at elevated risk for osteoporosis due to age, low body weight, smoking history, or family history, it’s reasonable to monitor bone health periodically during years of use.
Eye Problems: Cataracts and Glaucoma
Long-term inhaled corticosteroid use has been linked to increased risk of both cataracts and glaucoma, though the risk appears concentrated at higher doses. Research published in The BMJ found that people using high doses of inhaled steroids for more than three months were 44% more likely to develop glaucoma than non-users. Importantly, low and medium doses were not linked to increased glaucoma risk.
The threshold for “high dose” in that study was well above what most asthma patients use. But COPD patients prescribed the higher-strength Advair formulation for years may fall closer to that range. Cataracts develop gradually and painlessly, so they can go unnoticed without regular eye exams. If you’ve used Advair for several years, periodic eye checkups can catch elevated eye pressure or early lens clouding before they become significant problems.
Adrenal Gland Suppression
Your adrenal glands produce cortisol, a hormone your body relies on for stress response, blood sugar regulation, and immune function. When you inhale a corticosteroid daily, some of it enters your bloodstream and signals your brain to reduce its own cortisol production. Over months and years, this feedback loop can partially suppress your adrenal glands, a condition called adrenal suppression.
For most people on standard Advair doses, this suppression is mild and clinically insignificant. But it becomes relevant in two situations. First, if you’re suddenly taken off Advair after long-term use, your adrenal glands may not ramp up cortisol production fast enough, potentially causing fatigue, weakness, nausea, or dizziness. This is why tapering is generally preferred over abrupt discontinuation. Second, during severe physical stress like surgery, a major illness, or serious injury, your body needs a cortisol surge it may not be able to produce. Doctors managing your care in those situations need to know you’ve been on an inhaled corticosteroid.
Increased Susceptibility to Certain Infections
Beyond pneumonia, the immune-suppressing effects of Advair’s corticosteroid component can make certain infections more dangerous if you’re exposed. The FDA label specifically warns that chickenpox and measles can follow a more serious, even fatal course in people using corticosteroids who haven’t had these diseases or been vaccinated. While this is more of a concern for children, unvaccinated adults are also at risk.
People with active or dormant tuberculosis, systemic fungal infections, or certain viral infections like ocular herpes need particular caution. The corticosteroid doesn’t cause these infections, but it can allow them to progress or reactivate in ways they wouldn’t in someone with fully intact immune defenses. This is a consideration your prescriber should weigh if you have a history of these conditions.
Growth Effects in Children
Inhaled corticosteroids can slow growth velocity in children, typically by about 1 centimeter in the first year of use. Studies across multiple inhaled corticosteroids have consistently shown this small reduction. The effect tends to be most noticeable in the first year and often plateaus afterward, and most children appear to reach normal adult height. Still, pediatricians generally recommend using the lowest effective dose in children and monitoring growth regularly with standardized growth charts.
Reducing Your Long-Term Risks
Several practical steps lower the odds of these side effects. Rinsing your mouth with water and spitting after every dose is the single most effective habit for preventing thrush and reducing the amount of corticosteroid you swallow. Using Advair at the lowest dose that controls your symptoms limits systemic exposure. If your asthma or COPD has been well controlled for an extended period, your doctor may be able to step you down to a lower strength or transition you to a corticosteroid-free maintenance inhaler.
Keeping up with routine eye exams, bone density screening if you have risk factors, and staying current on vaccinations all help manage the less obvious long-term effects. The benefits of Advair in controlling airway disease are substantial, and for most people those benefits outweigh the risks. But understanding what to watch for puts you in a better position to catch problems early.